Literature DB >> 10202146

Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas.

J Peli1, M Schröter, C Rudaz, M Hahne, C Meyer, E Reichmann, J Tschopp.   

Abstract

Tumor growth is the result of deregulated tissue homeostasis which is maintained through the delicate balance of cell growth and apoptosis. One of the most efficient inducers of apoptosis is the death receptor Fas. We report here that oncogenic Ras (H-Ras) downregulates Fas expression and renders cells of fibroblastic and epitheloid origin resistant to Fas ligand-induced apoptosis. In Ras-transformed cells, Fas mRNA is absent. Inhibition of DNA methylation restores Fas expression. H-Ras signals via the PI 3-kinase pathway to downregulate Fas, suggesting that the known anti-apoptotic effect of the downstream PKB/Akt kinase may be mediated, at least in part, by the repression of Fas expression. Thus, the oncogenic potential of H-ras may reside on its capacity not only to promote cellular proliferation, but also to simultaneously inhibit Fas-triggered apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10202146      PMCID: PMC1171268          DOI: 10.1093/emboj/18.7.1824

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  52 in total

1.  Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis.

Authors:  I Herr; D Wilhelm; T Böhler; P Angel; K M Debatin
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

2.  Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras.

Authors:  P Rodriguez-Viciana; P H Warne; A Khwaja; B M Marte; D Pappin; P Das; M D Waterfield; A Ridley; J Downward
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

3.  Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway.

Authors:  A Khwaja; P Rodriguez-Viciana; S Wennström; P H Warne; J Downward
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

4.  Inhibition of death receptor signals by cellular FLIP.

Authors:  M Irmler; M Thome; M Hahne; P Schneider; K Hofmann; V Steiner; J L Bodmer; M Schröter; K Burns; C Mattmann; D Rimoldi; L E French; J Tschopp
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

5.  Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

Authors:  S Strand; W J Hofmann; H Hug; M Müller; G Otto; D Strand; S M Mariani; W Stremmel; P H Krammer; P R Galle
Journal:  Nat Med       Date:  1996-12       Impact factor: 53.440

6.  Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.

Authors:  F Leithäuser; J Dhein; G Mechtersheimer; K Koretz; S Brüderlein; C Henne; A Schmidt; K M Debatin; P H Krammer; P Möller
Journal:  Lab Invest       Date:  1993-10       Impact factor: 5.662

7.  FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway.

Authors:  E Gulbins; R Bissonnette; A Mahboubi; S Martin; W Nishioka; T Brunner; G Baier; G Baier-Bitterlich; C Byrd; F Lang
Journal:  Immunity       Date:  1995-04       Impact factor: 31.745

8.  DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1.

Authors:  S Kasibhatla; T Brunner; L Genestier; F Echeverri; A Mahboubi; D R Green
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

9.  Loss of Fas/Apo-1 receptor accelerates lymphomagenesis in E mu L-MYC transgenic mice but not in animals infected with MoMuLV.

Authors:  M Zörnig; A Grzeschiczek; M B Kowalski; K U Hartmann; T Möröy
Journal:  Oncogene       Date:  1995-06-15       Impact factor: 9.867

10.  Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells.

Authors:  C Friesen; I Herr; P H Krammer; K M Debatin
Journal:  Nat Med       Date:  1996-05       Impact factor: 53.440

View more
  44 in total

1.  MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly.

Authors:  T H Holmström; I Schmitz; T S Söderström; M Poukkula; V L Johnson; S C Chow; P H Krammer; J E Eriksson
Journal:  EMBO J       Date:  2000-10-16       Impact factor: 11.598

2.  Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin.

Authors:  Janiel M Shields; Heena Mehta; Kevin Pruitt; Channing J Der
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

3.  Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis.

Authors:  H Roelofs; M C Mostert; K Pompe; G Zafarana; M van Oorschot; R J van Gurp; A J Gillis; H Stoop; B Beverloo; J W Oosterhuis; C Bokemeyer; L H Looijenga
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 4.  Redefining regulation of DNA methylation by RNA interference.

Authors:  Viswanathan Muthusamy; Marcus Bosenberg; Narendra Wajapeyee
Journal:  Genomics       Date:  2010-07-08       Impact factor: 5.736

5.  Oncogenic KRAS regulates BMP4 expression in colon cancer cell lines.

Authors:  Eva-Maria Duerr; Yusuke Mizukami; Kentaro Moriichi; Manish Gala; Won-Seok Jo; Hirotoshi Kikuchi; Ramnik J Xavier; Daniel C Chung
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-01       Impact factor: 4.052

6.  Fas palmitoylation by the palmitoyl acyltransferase DHHC7 regulates Fas stability.

Authors:  A Rossin; J Durivault; T Chakhtoura-Feghali; N Lounnas; L Gagnoux-Palacios; A-O Hueber
Journal:  Cell Death Differ       Date:  2014-10-10       Impact factor: 15.828

Review 7.  Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine.

Authors:  Robert S Chapkin; Jeongmin Seo; David N McMurray; Joanne R Lupton
Journal:  Chem Phys Lipids       Date:  2008-03-04       Impact factor: 3.329

8.  RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.

Authors:  Thomas Sebastian; Peter F Johnson
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

Review 9.  Mechanisms in epithelial plasticity and metastasis: insights from 3D cultures and expression profiling.

Authors:  Martin Jechlinger; Stefan Grünert; Hartmut Beug
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

10.  DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases.

Authors:  Martin J Aryee; Wennuan Liu; Julia C Engelmann; Philipp Nuhn; Meltem Gurel; Michael C Haffner; David Esopi; Rafael A Irizarry; Robert H Getzenberg; William G Nelson; Jun Luo; Jianfeng Xu; William B Isaacs; G Steven Bova; Srinivasan Yegnasubramanian
Journal:  Sci Transl Med       Date:  2013-01-23       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.